Showing 1 to 2 of 2 results


Purdue Pharma Offers $7 Billion Opioid Settlement, Sackler Family to Relinquish Ownership
Purdue Pharma proposes a $7 billion settlement to resolve OxyContin lawsuits, with the Sackler family relinquishing ownership and contributing funds over 15 years, addressing past concerns by allowing plaintiffs to opt-in to the deal and potentially receive more than $850 million.
Purdue Pharma Offers $7 Billion Opioid Settlement, Sackler Family to Relinquish Ownership
Purdue Pharma proposes a $7 billion settlement to resolve OxyContin lawsuits, with the Sackler family relinquishing ownership and contributing funds over 15 years, addressing past concerns by allowing plaintiffs to opt-in to the deal and potentially receive more than $850 million.
Progress
40% Bias Score

Sackler Family, Purdue Pharma Settle Opioid Lawsuits for $7.4 Billion
Purdue Pharma and the Sackler family agreed to a $7.4 billion settlement to resolve lawsuits claiming their opioid painkiller OxyContin fueled the U.S. opioid crisis, following a Supreme Court ruling that overturned a previous bankruptcy deal that granted the Sacklers immunity.

Sackler Family, Purdue Pharma Settle Opioid Lawsuits for $7.4 Billion
Purdue Pharma and the Sackler family agreed to a $7.4 billion settlement to resolve lawsuits claiming their opioid painkiller OxyContin fueled the U.S. opioid crisis, following a Supreme Court ruling that overturned a previous bankruptcy deal that granted the Sacklers immunity.
Progress
36% Bias Score
Showing 1 to 2 of 2 results